CDE ID,CDE Name,Variable Name,Definition,Short Description,Question Text,Permissible Values,PV Descriptions,Data Type,Disease Specific Instructions,Disease Specific Reference,Population,"Classification (e.g., Core)",Version Number,Version Date,CRF Module / Guideline,Subdomain Name,Domain Name,Size,Input Restrictions,Min Value,Max Value,Measurement Type,External Id Loinc,External Id Snomed,External Id caDSR,External Id CDISC
C02212,Informed consent obtained date and time,InformConsntObtnDateTime,"Date (and time, if applicable and known) on which the participant/subject (or the legal representative on behalf of the participant/subject) agrees to participate in a protocol, treatment, or other activity by signing an informed consent document","Date (and time, if applicable and known) on which the participant/subject (or the legal representative on behalf of the participant/subject) agrees to participate in a protocol, treatment, or other activity by signing an informed consent docume",Date and time of informed consent,,,Date or Date & Time,"Record the date/time according to the ISO 8601, the International Standard for the representation of dates and times (http://www.iso.org/iso/home.html). The date/time should be recorded to the level of granularity known (e.g., year, year and month, complete date plus hours and minutes, etc.).",21 CFR 50.20 General requirements for informed consent A Guide to Informed Consent - Information Sheet: Guidance for Institutional Review Boards and Clinical Investigators Contents (http://www.fda.gov/RegulatoryInformation/Guidances/ucm126431.htm#general),Adult;Pediatric,Supplemental,3,21:25.6,Informed Consent,"Participant/Subject Identification, Eligibility, and Enrollment",Protocol Experience,,Free-Form Entry,,,,,,##########,
C02299,Informed consent type,InformConsntTyp,Type of informed consent obtained,Type of informed consent obtaine,Type of consent,Written informed consent by the participant/subject;Written informed consent by the legal representative on behalf of the participant/subject who gave assent;Written informed consent by the legal representative on behalf of the participant/subject who was unable to give assent;Waiver of consent,Written informed consent by the participant/subject;Written informed consent by the legal representative on behalf of the participant/subject who gave assent;Written informed consent by the legal representative on behalf of the participant/subject who was unable to give assent;Waiver of consent,Alphanumeric,Choose one.,21 CFR 50.20 General requirements for informed consent A Guide to Informed Consent - Information Sheet: Guidance for Institutional Review Boards and Clinical Investigators Contents (http://www.fda.gov/RegulatoryInformation/Guidances/ucm126431.htm#general),Adult;Pediatric,Supplemental,3,21:25.6,Informed Consent,"Participant/Subject Identification, Eligibility, and Enrollment",Protocol Experience,,Single Pre-Defined Value Selected,,,,,,,